ERBB2 and cancer: Preliminary evidence suggests that it is possible to apply deep-learning approaches to automatically predict cancer subtypes in multiple cancers6–8, predict mutations in lung6 and liver cancers9, classify mesothelioma10, detect DNA methylation patterns11, estimate human epidermal growth factor receptor 2 status in breast cancer12, and predict pan-cancer prognosis for patients13.